954-634-4400 / 888-844-2988

Blog - Monthly archives: July 2022

US DOJ Announces Criminal Charges for $1.2 Billion in Telemedicine, Cardiovascular and Cancer Genetic Testing and DME Fraud

Posted on Fraud Investigation, Health Care Law News July 21, 2022 by Rachel Broughton

On Wednesday, July 20, 2022, the United States Department of Justice (DOJ) announced criminal charges against 36 defendants in 13 federal districts across the United States for more than $1.2 billion in alleged fraudulent telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment (DME) schemes. In connection with the enforcement action, the department seized Read more →

Tags :

Navigating the Broad Implications of EKRA in the Substance Abuse and Diagnostic Laboratory Testing Industries

Posted on Fraud Investigation, Health Care Law News July 19, 2022 by Rachel Broughton

The Eliminating Kickbacks in Recovery Act, otherwise known as EKRA, is a fairly new federal law that targets patient brokering and recovery profiteering. EKRA broadly makes it a federal crime for anyone, with respect to services covered by any health care benefit program, to knowingly and willfully: solicit or receive any remuneration (including any kickback, Read more →

Tags : , , ,

US Supreme Court Rules There Is No Criminal Liability Under the Controlled Substance Act For Physicians Who Act in Subjective Good Faith

Posted on Health Care Law News, Professional Licensure Investigations July 1, 2022 by Rachel Broughton

 On June 27, 2022, the Supreme Court of the United States ruled that physicians who act in subjective good faith when prescribing controlled substances to their patients are shielded from criminal liability under the Controlled Substances Act (CSA).  This decision will make it much more difficult for prosecutors to convict medical professionals under the CSA Read more →

Tags :

Archives